BRIEF-Abbvie Inc - Q1 2025 Earnings Include $248 Million Ipr&D And Milestones Expense - SEC Filing

Reuters
04 Apr
BRIEF-Abbvie Inc - Q1 2025 Earnings Include $248 Million Ipr&D And Milestones Expense - SEC Filing

April 3 (Reuters) - Abbvie Inc ABBV.N:

  • Q1 2025 EARNINGS INCLUDE $248 MILLION IPR&D AND MILESTONES EXPENSE - SEC FILING

  • SEES FOR Q1 UNFAVORABLE IMPACT OF $0.13 TO GAAP AND NON-GAAP EPS - SEC FILING

  • Q1 2025 ADJUSTED EPS GUIDANCE $2.34 - $2.38 - SEC FILING

  • FULL-YEAR 2025 ADJUSTED EPS GUIDANCE $11.99 - $12.19 - SEC FILING

  • Q1 EARNINGS PER SHARE VIEW $2.51 -- LSEG IBES DATA

  • FY2025 EARNINGS PER SHARE VIEW $12.30 -- LSEG IBES DATA

Source text: [ID:n0001551152-25-000023]

Further company coverage: ABBV.N

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10